Deficiency in the endocytic adaptor proteins PHETA1/2 impairs renal and craniofacial development.
Ontology highlight
ABSTRACT: A critical barrier in the treatment of endosomal and lysosomal diseases is the lack of understanding of the in vivo functions of the putative causative genes. We addressed this by investigating a key pair of endocytic adaptor proteins, PH domain-containing endocytic trafficking adaptor 1 and 2 (PHETA1/2; also known as FAM109A/B, Ses1/2, IPIP27A/B), which interact with the protein product of OCRL, the causative gene for Lowe syndrome. Here, we conducted the first study of PHETA1/2 in vivo, utilizing the zebrafish system. We found that impairment of both zebrafish orthologs, pheta1 and pheta2, disrupted endocytosis and ciliogenesis in renal tissues. In addition, pheta1/2 mutant animals exhibited reduced jaw size and delayed chondrocyte differentiatio
SUBMITTER: Ates KM
PROVIDER: S-EPMC7272357 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
ACCESS DATA